| Term 
 | Definition 
 
        | tyrosine --> L-Dopa --> Dopamine --> Norepi --> Epi |  | 
        |  | 
        
        | Term 
 
        | Enzymes involved in metabolism |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Enzymes altering re-uptake |  | Definition 
 
        | Dopamine Transporter (DAT) Norepinephrine transporters (NET)- tricyclic antidepressants block this
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Block reuptake and reverse the transporter- lots of catecholamine release |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - G protein stimulates PLC, making IP3, DAG, and increasing Ca - primarily located in vessels in skin and gut
 - activation causes contraction
 - don't need a lot of blood in skin and gut
 - also get contraction of: pupillary dilator muscle, heart, GU tract
 - Phenylephrine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | - Inhibits AC, decreasing cAMP - direct opposition to betaAR?
 - when applied directly on vessel, it will contract
 - if given systemically, CNS sends out negative feedback leading to a decrease in heart rate and blood pressure
 - Overall decrease in norepi levels
 - peripheral actions: vasoconstriction when topical application, GI decreased secretion and motility, pancrease decreased release of insulin, decreased lipolysis, decreased aqueous humor production
 - Clonidine- decreases BP
 - oxymetazoline- topically for congestion
 - apraclonidine- topically for glaucoma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - alpha2AR agonist - for hypertension because it decreases BP
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - alpha2AR agonist - apply topically for congestion
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - alpha2AR agonist - apply topically for glaucoma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - GPCR that stimulates AC to make more cAMP - heart- stimulates rate and force of contractions
 - kidney- stimulates renin release by JGC's, renin increases BP
 - dobutamine- increases cardiac output with less reflex tachycardia than non-selective B agonists
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | B1AR agonist - increases cardiac output with less reflex tachycardia than non-selective B agonists
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - GCPR stimulating AC to make cAMP - bronchi, uterus, bladder- relaxes vascular smooth muscle
 - cardiovascular- relaxes peripheral vascular resistance, so increases HR
 - skeletal muscle- increases potassium uptake (increasing contraction)
 - liver- stimulates glycogenolysis
 - pancreatic B cells- stimulates insulin release
 - Albuterol (asthma), terbutaline(acute bronchospasm, premature labor), salmeterol (chronic bronchospasm)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - B2AR agonist - Use for asthma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - B2AR agonist - Use for acute bronchospasm and premature labor
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - B2AR agonist - chronic bronchospasm
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - least understood, may stimulate lipolysis - seems to be involved in heart failure
 - relaxes detrusor muscles in bladder
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | - When GRK comes in and phosphorylates B2 receptor, arrestin comes in and internalizes this receptor - 2 possible outcomes: 1. resensitization 2. downregulated (not returned to surface)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - blocks reuptake of dopamine via DAT |  | 
        |  |